Federal Register Notice: FDA’s Oncologic Drugs Advisory Committee will meet 3/21, from 8 a.m. to 12:45 p.m. at the FDA White Oak Campus, 10903 New Hampshire Ave., Bldg. 31, Conference Center, the Great Room (Rm. 1503), Silver Spring, MD. The committee will a Talon Therapeutics NDA for Marquibo (vincristine sulfate liposomes injection) for treating adult patients with Philadelphia chromosome-negative acute lymphoblastic leukemia in second or greater relapse or whose disease has progressed following two or more treatment lines of anti-leukemia therapy. Contact Caleb Briggs, (301) 796-9001. To view this notice, click here.